Cargando…

Erratum to DYRK1A suppression restrains Mcl-1 expression and sensitizes NSCLC cells to Bcl-2 inhibitors

Detalles Bibliográficos
Autores principales:	Li, Yangling, Zhou, Dongmei, Xu, Shuang, Rao, Mingjun, Zhang, Zuoyan, Wu, Linwen, Zhang, Chong, Lin, Nengming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Compuscript 2022
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334766/ https://www.ncbi.nlm.nih.gov/pubmed/35532134 http://dx.doi.org/10.20892/j.issn.2095-3941.2022.0172

Ejemplares similares

DYRK1A suppression restrains Mcl-1 expression and sensitizes NSCLC cells to Bcl-2 inhibitors
por: Li, Yangling, et al.
Publicado: (2020)

Erratum: Stromal Hedgehog signalling is downregulated in colon cancer and its restoration restrains tumour growth
por: Gerling, Marco, et al.
Publicado: (2016)

Erratum: Antigen-affinity controls pre-germinal center B cell selection by promoting Mcl-1 induction through BAFF receptor signaling
por: Wensveen, Felix M., et al.
Publicado: (2017)

Erratum: Structural Mechanism for Regulation of Bcl-2 protein Noxa by phosphorylation
por: Karim, Christine B., et al.
Publicado: (2015)

Erratum to: NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin
por: Suwei, Dong, et al.
Publicado: (2016)

Erratum: Diagnostic and therapeutic update of mantle cell lymphoma (MCL): analysis of seven cases treated in a centre in one year
por: Herrero-Vicent, Carmen, et al.
Publicado: (2016)

Erratum: Functional BCL-2 regulatory genetic variants contribute to susceptibility of esophageal squamous cell carcinoma
por: Pan, Wenting, et al.
Publicado: (2015)

ERRATUM 1
Publicado: (2010)

DYRK1A inhibition suppresses STAT3/EGFR/Met signalling and sensitizes EGFR wild‐type NSCLC cells to AZD9291
por: Li, Yang‐ling, et al.
Publicado: (2019)

Dual target gene therapy to EML4-ALK NSCLC by a gold nanoshell-based system: Erratum
por: Li, Siwen, et al.
Publicado: (2020)

Inhibition of Antiapoptotic BCL-XL, BCL-2, and MCL-1 Proteins by Small Molecule Mimetics
por: Dalafave, D.S., et al.
Publicado: (2010)

BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival
por: Lee, Erinna F., et al.
Publicado: (2019)

Erratum Vol. 8, No. 1
Publicado: (2002)

Erratum: Vol. 66, No. 1
Publicado: (2017)

Erratum: Vol. 71, No. 1
Publicado: (2022)

Dual targeting of BCL2 and MCL1 rescues myeloma cells resistant to BCL2 and MCL1 inhibitors associated with the formation of BAX/BAK hetero-complexes
por: Seiller, Carolane, et al.
Publicado: (2020)

Erratum to “Liproxstatin-1 Protects Hair Cell-Like HEI-OC1 Cells and Cochlear Hair Cells against Neomycin Ototoxicity”
por: Zheng, Zhiwei, et al.
Publicado: (2021)

Erratum
por: Yim, Jisook, et al.
Publicado: (2015)

Erratum, Vol. 5: Issue 1
Publicado: (2008)

Erratum, Vol. 5: Issue 1
Publicado: (2008)

Erratum, Vol. 7: Issue 1
Publicado: (2010)

Erratum, Vol. 6: Issue 1
Publicado: (2009)

Erratum, Vol. 6: Issue 1
Publicado: (2009)

Erratum: Vol. 60, No. RR-1
Publicado: (2017)

Erratum: Vol. 67, No. SS-1
Publicado: (2018)

Erratum: Vol. 69, No. Suppl. 1
Publicado: (2020)

Erratum: Vol. 62, No. RR-1
Publicado: (2021)

Erratum: Vol. 72, No. Suppl-1
Publicado: (2023)

Erratum: Vol. 72, No. RR-1
Publicado: (2023)

Effects of Galectin-1 on Biological Behavior in Cervical Cancer: Erratum
por: Chetry, Mandika, et al.
Publicado: (2022)

Erratum: General peroxidase activity of a parallel G-quadruplex-hemin DNAzyme formed by Pu39WT - a mixed G-quadruplex forming sequence in the Bcl-2 P1 promoter
por: Liu, Bo, et al.
Publicado: (2014)

Correction to: BCL2L2 loss renders ‐14q renal cancer dependent on BCL2L1 that mediates resistance to tyrosine kinase inhibitors
por: Lyu, Yinfeng, et al.
Publicado: (2023)

Erratum to erratum to protective effect of hydrogen sulfide on endothelial cells through Sirt1-FOXO1 mediated autophagy
Publicado: (2022)

Erratum to: RIZ1: a potential tumor suppressor in glioma
por: Zhang, Chenran, et al.
Publicado: (2016)

Erratum to "LRIG1 Enhances Chemosensitivity by Modulating BCL-2 Expression and Receptor Tyrosine Kinase Signaling in Glioma Cells" by Guo Z, et al. (Yonsei Med J 2014;55:1196-205.)
Publicado: (2014)

Erratum to: Are T cells the only HIV-1 reservoir?
por: Kandathil, Abraham Joseph, et al.
Publicado: (2017)

Erratum for Euro Surveill. 2019;24(1)
Publicado: (2019)

Erratum for Euro Surveill. 2017;22(1)
Publicado: (2017)

Erratum for Euro Surveill. 2023;28(1)
Publicado: (2023)

A randomized, multi-center, open-label study to compare the safety and efficacy between afatinib monotherapy and combination therapy of afatinib and HAD-B1 for the locally advanced or metastatic NSCLC patients with EGFR mutations: Erratum
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8moakcf0jfm69uuvv0ls6qo1un